10/6 2021

Lumen Bioscience awarded federal funding to advance Covid-19 antibody cocktail through Phase 2 Clinical Evaluation

2021-10-06T19:54:41+00:00October 6th, 2021|ATI in the News|

Lumen Bioscience—a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases—today announced new development funding from the US Army for its Covid-19 monoclonal antibody drug cocktail. The support is provided by the US Army Medical Research and Development Command (USAMRDC), operating through the Medical Technology Enterprise Consortium (MTEC).

10/4 2021

U.S. Defense Department Awards $8.9 Million for Further R&D On Lead-Free Electronics in Aerospace and Defense Sectors

2021-10-11T14:17:34+00:00October 4th, 2021|ATI in the News|

The U.S. Partnership for Assured Electronics (USPAE) is the recipient of a $8.9 million award from the DoD Office of Industrial Policy’s Industrial Base Analysis and Sustainment (IBAS) Program to grow the Defense Electronics Consortium (DEC) and expand its work on the Lead-Free Defense Electronics Project.

10/1 2021

UAB to study hand-held device that monitors traumatic brain injury

2021-10-04T20:06:31+00:00October 1st, 2021|ATI in the News|

Researchers at the University of Alabama at Birmingham will investigate the usefulness of a new non-invasive method to measure the expansion of hematomas in the brain. This project is funded by the Combat Casualty Care Research Program’s Neurotrauma Program at the US Army Medical Research and Development Command via the Medical Technology Enterprise Consortium.

9/28 2021

Mitochon Pharmaceuticals and University of Kentucky Awarded MTEC Grant for MP-201 in Traumatic Brain Injury

2021-09-29T15:09:46+00:00September 28th, 2021|ATI in the News|

Mitochon Pharmaceuticals today is pleased to announce the receipt of a $500,000 grant in conjunction with the University of Kentucky for “Advancement of Drugs for the Treatment of Repeated Mild Traumatic Brain Injury (mTBI)” through a joint funded program by an Alzheimer’s Disease group, BrightFocus Foundation and a military focused foundation, Medical Technology Enterprise Consortium (MTEC).

9/22 2021

ECS Awarded NIWC Legacy Data Consolidation Solution Contract

2021-09-27T11:37:10+00:00September 22nd, 2021|ATI in the News|

ECS, a leader in advanced technology, science, and digital transformation solutions, has been awarded the Naval Information Warfare Center (NIWC) Atlantic Legacy Data Consolidation Solution (LDCS) Other Transaction Agreement (OTA). This program was awarded via the Information Warfare Research Project (IWRP) to support its work for the Defense Health Agency (DHA) Program Executive Office (PEO) Defense Healthcare Management Systems (DHMS), Enterprise Intelligence and Data Solutions (EIDS) Program Management Office (PMO).

9/21 2021

Pulmotect Reports Positive Topline Results from Randomized, Placebo Controlled Phase-2 Trial of PUL-042 against COVID-19

2021-09-22T12:28:01+00:00September 21st, 2021|ATI in the News|

Pulmotect, Inc., a clinical-stage biotechnology company, announced positive topline results from the first of two Phase-2 clinical trials undertaken with the support of the US Department of Defense (DOD) to evaluate PUL-042 against COVID-19. The Phase 2 studies of PUL-042 for COVID-19 are funded in part with federal funds from the DOD’s Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical (JPM CBRN Medical), through the U.S. Army Contracting Command - New Jersey, under an Other Transaction Agreement (W15QKN-16-9-1002, Project #MCDC 2006-002) awarded to the Medical CBRN Defense Consortium and Pulmotect, Inc.

Go to Top